Histological classification and molecular genetics of meningiomas (Q36655595)

15 August 2017

1 reference

title

Histological classification and molecular genetics of meningiomas (English)

1 reference

15 August 2017

1 reference

3

Guido Reifenberger

1 reference

15 August 2017

author name string

Markus J Riemenschneider

series ordinal

1

1 reference

15 August 2017

Arie Perry

series ordinal

2

1 reference

15 August 2017

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

5

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

1045-1054

1 reference

Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The relapsing course of certain meningiomas in relation to pregnancy and menstruation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Hereditary tumor syndromes of the nervous system: overview and rare syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Meningiomas may be a component tumor of multiple endocrine neoplasia type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

NF2 mutations in secretory and other rare variants of meningiomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Meningioma grading: an analysis of histologic parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Chordoid meningioma: a clinicopathologic study of 42 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Effect of embolisation of meningioma on Ki-67 proliferation index

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Papillary meningioma: A malignant variant of meningioma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Papillary meningioma. Clinicopathologic study of seven cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Rhabdoid transformation of tumor cells in meningiomas: a histologic indication of increased proliferative activity: report of four cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

"Rhabdoid" meningioma: an aggressive variant.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Immunohistochemical profile of meningiomas and their histological subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Progesterone and estrogen receptors in meningiomas: prognostic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Molecular genetic approach to human meningioma: loss of genes on chromosome 22

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Deletions on chromosome 22 in sporadic meningioma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Predominant occurrence of somatic mutations of theNF2 gene in meningiomas and schwannomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Genetic and epigenetic alteration of theNF2gene in sporadic meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Schwannomin isoform-1 interacts with syntenin via PDZ domains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Merlin differentially associates with the microtubule and actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motility

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

p21-activated kinase links Rac/Cdc42 signaling to merlin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Protein 4.1B/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Structure of the promoter and genomic organization of the human beta'-adaptin gene (BAM22) from chromosome 22q12

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

INI1 mutations in meningiomas at a potential hotspot in exon 9

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

High-resolution analysis of chromosome arm 1p alterations in meningioma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Analysis of p73 gene in meningiomas with deletion at 1p.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Methylation status of TP73 in meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Analysis of the PTEN gene in human meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

PS6K amplification characterizes a small subset of anaplastic meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Prognostic value of allelic losses and telomerase activity in meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

1 reference

7 January 2021

The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The Rb/E2F pathway and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

p14ARF links the tumour suppressors RB and p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Meningioma transcript profiles reveal deregulated Notch signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

The epidermal growth factor receptor is associated with phospholipase C-gamma 1 in meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Epidermal growth factor receptor expression in 72 meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Expression and activation of epidermal growth factor receptors in meningiomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

TGF alpha expression in meningioma--tumor progression and therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Autocrine control of human meningioma proliferation: secretion of platelet-derived growth-factor-like molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Induction of apoptosis in primary meningioma cultures by fenretinide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

A genetic strategy to overcome the senescence of primary meningioma cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Establishment of a benign meningioma cell line by hTERT-mediated immortalization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

Mouse models of neurofibromatosis 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970625-1

7 January 2021

10.1016/S1474-4422(06)70625-1

Identifiers

DOI

1 reference

15 August 2017

1 reference